Archive
Feb. 27, 2020
Early Access to Unapproved Medicines in the United States and France
Feb. 27, 2020
Distorted Drug Patents
Feb. 27, 2020
Mere Common Ownership and the Antitrust Laws
Feb. 27, 2020
After Espinoza: What’s Left of the Establishment Clause?
Feb. 27, 2020
Reflections on COVID-19, Insurance, Business Interruption, Systemic Risk, and the Future
Feb. 27, 2020
Tam Through the Lens of Brunetti: The SLANTS, FUCT
Feb. 27, 2020
Covid-19 and the Continuing Asian American Moment: Narratives from the Midwest
Feb. 16, 2020
Into the Weeds: Modern Discrimination Law
Feb. 16, 2020
The Emerging Statutory Proximate Cause Doctrine
Feb. 16, 2020